MedPath
NMPA Approval

Irinotecan Hydrochloride Injection

国药准字H20143127

January 23, 2024

Drug Information

盐酸伊立替康注射液

科瑞

注射剂

2ml:40mg(按 C₃₃H₃₈N₄O₆·HCl·3H₂O 计)

化学药品

January 23, 2024

Company Information

Applicant Company

海口市南海大道海口保税区8号厂房

Manufacturing Company

海口市南海大道海口保税区8号厂房北面中部

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸伊立替康注射液 - NMPA 批准文号 | MedPath